Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 31, 2018 09:00 ET | Source: Biodesix, Inc.

Biodesix Announces PD-L1 Collaboration with Professor Fred R. Hirsch

BOULDER, Colo., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Biodesix® announced a new collaboration agreement with PD-L1 expert Professor Fred R. Hirsch, MD, PhD, laboratory director at the Hirsch Biomarker...
January 19, 2018 16:56 ET | Source: Biodesix, Inc.

MEDIA ADVISORY -- Dr. Heinrich Roder, Biodesix CTO, To Speak At Precision Medicine World Conference

ADVISORY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- WHAT: Dr. Heinrich Roder, Biodesix’ CTO, will speak on “Applied Machine Learning for Immuno-Oncology Diagnostics” in the “AI and Data Science Showcase”...
December 20, 2017 10:00 ET | Source: Biodesix, Inc.

Data Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors

BOULDER, Colo., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Findings published in the American Association for Cancer Research (AACR) peer-reviewed journal Cancer Immunology Research demonstrate that a test...
December 05, 2017 06:00 ET | Source: Biodesix, Inc.

Biodesix Leaders Share Commercial and Pipeline Updates at Annual qPCR and dPCR Congress

BOULDER, Colo., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Biodesix provided updates and data related to the company’s on-market and in-development liquid biopsy tests at the 2017 qPCR & Digital PCR...
November 16, 2017 15:40 ET | Source: Biodesix, Inc.

Biodesix Announces New Data Demonstrating Analytic Validity of Automated RNA Extraction from Plasma with the GeneStrat® Test

BOULDER, Colo., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Biodesix® announced data demonstrating that a novel, automated method for extracting circulating RNA from plasma performed equivalently or better...
November 07, 2017 12:22 ET | Source: Biodesix, Inc.

Biodesix Oral Presentation At SITC: Testing Methodology May Identify Primary Immunotherapy Resistance In Patients

BOULDER, Colo., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Biodesix® chief technology officer, Dr. Heinrich Roder, will give an oral presentation discussing a proprietary test development methodology that...
November 01, 2017 12:12 ET | Source: Biodesix, Inc.

Biodesix Blood-Based Diagnostic Testing Approach To PD-L1 Detection Shows Concordance with Immunohistochemistry

BOULDER, Colo., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Biodesix® presented preliminary data evaluating a blood-based PD-L1 assay to identify patients who may benefit from cancer immunotherapies. The data...
October 25, 2017 10:00 ET | Source: Biodesix, Inc.

Biodesix To Present Data at SITC Annual Meeting

BOULDER, Colo., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Biodesix will conduct an oral presentation on immunotherapy biomarkers in addition to presenting data from two separate studies at the SITC 2017...
September 28, 2017 13:42 ET | Source: Biodesix, Inc.; The Society for Advanced Bronchoscopy

Introducing The Society For Advanced Bronchoscopy

TAMPA, Fla., Sept. 28, 2017 (GLOBE NEWSWIRE) -- The Society for Advanced Bronchoscopy announced its inception and plans for its first annual meeting today, citing the need to “promote and support...
September 20, 2017 11:17 ET | Source: Biodesix, Inc.

Study Published In Managed Care Regarding Prognostic and Cancer-Care Planning Value of Biodesix’s VeriStrat® Proteomic Test

BOULDER, Colo., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Findings published in the peer-reviewed journal Managed Care showed that prognostic information provided by the Biodesix® VeriStrat test can...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right